Project Oncology®
Showcasing major breakthroughs in cancer care from worldwide clinical trials, Project Oncology® educates and assists the healthcare professionals who dedicate their lives to helping patients fight cancer.
Here you’ll find leading oncologists discuss and share essential cancer care strategies for all different types of cancer. And as worldwide clinical trials continue to explore new screening tests and discover novel treatment options, you can rest assured that you’ll always catch the latest in cancer research with Project Oncology®.

What Is on the ‘HERIZON’ in 1L HER2+ Gastroesophageal Adenocarcinoma?
Medical Industry FeatureWhat Is on the ‘HERIZON’ in 1L HER2+ Gastroesophageal Adenocarcinoma?

R/R LBCL: A Practical Guide to CAR T Referral and Coordination
Project Oncology®R/R LBCL: A Practical Guide to CAR T Referral and Coordination

The First Approved All-Oral, Fixed Duration Treatment for CLL: Insights from the AMPLIFY Trial
Project Oncology®The First Approved All-Oral, Fixed Duration Treatment for CLL: Insights from the AMPLIFY Trial

Advancing Care in Chronic GVHD: Evolving Therapeutic Insights
Project Oncology®Advancing Care in Chronic GVHD: Evolving Therapeutic Insights

Ocular Management in PROC: Insights on Collaborative Care Across Practice Settings
Project Oncology®Ocular Management in PROC: Insights on Collaborative Care Across Practice Settings

ReDiscover-2: Currently Enrolling Patients With PIK3CA-Mutated Advanced Breast Cancer
Medical Industry FeatureReDiscover-2: Currently Enrolling Patients With PIK3CA-Mutated Advanced Breast Cancer
- advertisement

Exploring Sub-Ablative Radiation to Modulate Immunity in Mesothelioma
Project Oncology®Exploring Sub-Ablative Radiation to Modulate Immunity in Mesothelioma

From Durability to Discovery: Advances in ALK+ mNSCLC Treatment
Project Oncology®From Durability to Discovery: Advances in ALK+ mNSCLC Treatment

How Novel Strategies Could Push ALK+ mNSCLC Care Forward
Project Oncology®How Novel Strategies Could Push ALK+ mNSCLC Care Forward

How ALK Vaccines Could Prolong TKI Response in mNSCLC
Project Oncology®How ALK Vaccines Could Prolong TKI Response in mNSCLC

Patterns of Progression and Resistance in ALK+ mNSCLC
Project Oncology®Patterns of Progression and Resistance in ALK+ mNSCLC

Guiding mNSCLC Treatment After ALK-TKI Progression
Project Oncology®Guiding mNSCLC Treatment After ALK-TKI Progression
- advertisement

Dialogue with the Experts: Best Practices in NSCLC
CME/CEDialogue with the Experts: Best Practices in NSCLC
- 10/12/2026
- 10/12/2026
- 10/12/2026
- 10/12/2026
- 10/09/2026
- 10/09/2026















































